Sercan Aksoy Selected Research

Sercan Aksoy Research Topics

Disease

66	Neoplasms (Cancer) 03/2024 - 01/2004
56	Breast Neoplasms (Breast Cancer) 03/2024 - 01/2004
19	Neoplasm Metastasis (Metastasis) 03/2024 - 11/2005
8	Cardiotoxicity 12/2023 - 05/2005
7	Triple Negative Breast Neoplasms 07/2023 - 04/2009
7	Disease Progression 02/2023 - 01/2012
7	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 01/2015
6	Colorectal Neoplasms (Colorectal Cancer) 03/2015 - 01/2013
6	Lymphoma (Lymphomas) 03/2009 - 04/2004
5	Squamous Cell Carcinoma of Head and Neck 03/2024 - 01/2017
5	Infections 01/2021 - 01/2006
5	Carcinoma (Carcinomatosis) 01/2017 - 10/2006
5	Stomach Neoplasms (Stomach Cancer) 02/2016 - 01/2011
4	Acute Kidney Injury (Acute Renal Failure) 03/2024 - 01/2013
4	Nasopharyngeal Carcinoma 05/2023 - 01/2004
4	Osteoporosis 01/2016 - 03/2011
3	Neutropenia 03/2024 - 03/2009
3	Sarcopenia 12/2023 - 01/2023
3	Head and Neck Neoplasms (Head and Neck Cancer) 01/2023 - 06/2021
3	Obesity 01/2016 - 01/2006
3	Adenocarcinoma 01/2014 - 01/2010
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2009 - 07/2007
2	Deglutition Disorders (Dysphagia) 03/2024 - 08/2023
2	Stomatitis 03/2024 - 07/2021
2	Anemia 11/2023 - 07/2021
2	Vomiting 01/2023 - 10/2021
2	Fatigue 01/2023 - 07/2021
2	Male Breast Neoplasms (Male Breast Cancer) 12/2022 - 06/2012
2	Hypoalbuminemia 09/2022 - 01/2022
2	Renal Cell Carcinoma (Grawitz Tumor) 08/2022 - 09/2021
2	Rheumatic Diseases (Rheumatism) 01/2021 - 02/2019
2	Hematologic Neoplasms (Hematological Malignancy) 02/2019 - 01/2005
2	Heart Failure 03/2015 - 12/2014
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 07/2014 - 08/2006
2	Chronic Hepatitis (Chronic Active Hepatitis) 06/2014 - 05/2008

Drug/Important Bio-Agent (IBA)

15	Hormones (Hormone)IBA 03/2024 - 05/2008
14	Trastuzumab (Herceptin)FDA Link 04/2023 - 01/2012
9	Immune Checkpoint InhibitorsIBA 11/2023 - 03/2020
8	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2015 - 01/2004
7	AnthracyclinesIBA 03/2024 - 10/2014
7	ErbB Receptors (EGF Receptor)IBA 02/2024 - 01/2012
7	Biomarkers (Surrogate Marker)IBA 11/2023 - 03/2015
7	pertuzumabIBA 04/2023 - 01/2012
7	Aromatase InhibitorsIBA 03/2023 - 10/2008
7	Fluorouracil (Carac)FDA LinkGeneric 01/2017 - 03/2005
6	Cisplatin (Platino)FDA LinkGeneric 08/2023 - 01/2004
6	Capecitabine (Xeloda)FDA Link 07/2015 - 03/2005
6	Rituximab (Mabthera)FDA Link 06/2014 - 03/2006
5	Ado-Trastuzumab EmtansineIBA 02/2024 - 04/2013
5	Paclitaxel (Taxol)FDA LinkGeneric 04/2023 - 05/2005
5	Diphosphonates (Bisphosphonates)IBA 01/2013 - 01/2004
4	Immunoconjugates (Immunoconjugate)IBA 02/2024 - 04/2013
4	Estrogen ReceptorsIBA 11/2023 - 02/2011
4	Docetaxel (Taxotere)FDA Link 04/2023 - 09/2014
4	taxaneIBA 07/2021 - 04/2013
4	Zoledronic Acid (Zometa)FDA Link 01/2016 - 01/2008
4	Leucovorin (Folinic Acid)FDA Link 09/2014 - 01/2010
4	Oxaliplatin (Eloxatin)FDA LinkGeneric 09/2014 - 01/2011
4	Ifosfamide FDA LinkGeneric 01/2012 - 01/2004
3	pembrolizumabIBA 03/2024 - 06/2020
3	Fulvestrant (Faslodex)FDA Link 03/2024 - 08/2021
3	palbociclibIBA 03/2024 - 03/2023
3	ribociclibIBA 03/2024 - 03/2023
3	human ERBB2 proteinIBA 12/2023 - 01/2011
3	Tamoxifen FDA LinkGeneric 11/2023 - 01/2004
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2023 - 02/2014
3	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 09/2021 - 01/2014
3	Everolimus FDA Link 07/2021 - 01/2014
3	exemestane (Aromasin)FDA Link 07/2021 - 01/2014
3	abirateroneIBA 01/2021 - 05/2019
3	Lapatinib (GW572016)FDA Link 06/2014 - 04/2013
3	Bevacizumab (Avastin)FDA Link 01/2014 - 01/2011
3	PlatinumIBA 11/2013 - 01/2004
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 02/2024 - 11/2022
2	NivolumabIBA 11/2023 - 09/2021
2	Proteins (Proteins, Gene)FDA Link 05/2023 - 01/2023
2	Prostate-Specific Antigen (Semenogelase)IBA 01/2023 - 05/2019
2	Cyclin-Dependent Kinase 4IBA 12/2022 - 11/2022
2	AlbuminsIBA 01/2022 - 01/2022
2	Androgen Receptors (Androgen Receptor)IBA 01/2021 - 09/2018
2	RNA (Ribonucleic Acid)IBA 01/2020 - 05/2008
2	Abiraterone AcetateIBA 10/2019 - 05/2019
2	TOR Serine-Threonine KinasesIBA 01/2016 - 06/2014
2	Tyrosine Kinase InhibitorsIBA 01/2016 - 06/2014
2	C-Reactive ProteinIBA 03/2015 - 10/2009
2	Cytotoxins (Cytolysins)IBA 02/2015 - 04/2013
2	Phenobarbital (Luminal)FDA Link 01/2015 - 04/2009
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2015 - 07/2007

Therapy/Procedure

38	Therapeutics 03/2024 - 01/2005
37	Drug Therapy (Chemotherapy) 03/2024 - 01/2004
14	Radiotherapy 08/2023 - 03/2008
10	Immunotherapy 05/2023 - 01/2016
8	Chemoradiotherapy 03/2024 - 01/2010
5	Neoadjuvant Therapy 07/2023 - 10/2012
4	Castration 01/2023 - 05/2019
2	Drug Tapering 03/2024 - 01/2006
2	Polypharmacy 06/2022 - 04/2021
2	Gastrectomy 02/2016 - 10/2012
2	Duration of Therapy 03/2015 - 12/2014
2	Adjuvant Chemotherapy 10/2014 - 01/2013